Journal profile · Toxicology
Therapeutic Drug Monitoring
ISSN 0163-4356 · eISSN 1536-3694 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1979
Therapeutic Drug Monitoring: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.16; JCR Q2 (journal website); hybrid open access; median 75 days to acceptance (84 articles, last 24 months); community-reported acceptance: fairly easy; 129 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Therapeutic Drug Monitoring is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacological Effects and Toxicity Studies, Antibiotics Pharmacokinetics and Efficacy and Renal Transplantation Outcomes and Treatments, together about 33.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Therapeutic Drug Monitoring is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. It fosters the exchange of knowledge among the various disciplines–clinical pharmacology, pathology, toxicology, analytical chemistry–that share a common interest in Therapeutic Drug Monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs, original articles, case reports, technical notes, and continuing education articles.
Source: LetPub
Research area (LetPub): Toxicology
Editor-in-chief Uwe ChristiansPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacological Effects and Toxicity StudiesMedicine12.4%
- Antibiotics Pharmacokinetics and EfficacyMedicine11.9%
- Renal Transplantation Outcomes and TreatmentsMedicine9.4%
- Epilepsy research and treatmentMedicine8.1%
- Analytical Methods in PharmaceuticalsChemistry6.1%
- Pharmaceutical studies and practicesMedicine6.1%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics5.5%
- HIV/AIDS drug development and treatmentMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 3 |
| Minor | Toxicology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Toxicology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 3 |
| Minor | Toxicology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · MEDICAL LABORATORY TECHNOLOGY · rank 14/33
- JCR Q3 · PHARMACOLOGY & PHARMACY · rank 226/356
- JCR Q3 · TOXICOLOGY · rank 78/106
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.16LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.2LetPub ·
- SJR 2026-06
- 0.59LetPub ·
- SNIP 2026-06
- 0.97LetPub ·
- h-index
- 87LetPub ·
- h-index
- 121OpenAlex ·
- i10-index
- 3,324OpenAlex ·
- 2-year mean citedness
- 1.83OpenAlex ·
- Self-citation rate
- 8.7%LetPub ·
- Share of gold OA articles
- 23.29%LetPub ·
Volume
- Articles per year
- 113LetPub ·
Articles by year OpenAlex count · 6,773 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 89 | 32 | 22 |
| 2025 | 129 | 50 | 184 |
| 2024 | 161 | 42 | 488 |
| 2023 | 111 | 44 | 849 |
| 2022 | 95 | 31 | 730 |
| 2021 | 91 | 34 | 1,327 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
75 daysMedian, submission to acceptance · P25–P75 57 days – 106 days
- Acceptance to online
- median 60 days (85 articles)
- Submission to online
- median 145 days
- Sample
- 84 articles with submission and acceptance dates (256 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1979
- ISSN
- 0163-4356
- Electronic ISSN
- 1536-3694
- Latest issue on the website
- Volume 48, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Therapeutic Drug Monitoring
What CAS zone is Therapeutic Drug Monitoring in?
In the 2025 upgraded edition of the CAS Journal Ranking, Therapeutic Drug Monitoring is in Zone 4 of Medicine, and in Zone 3 of the minor category Medical Laboratory Technology / Toxicology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Therapeutic Drug Monitoring?
The latest impact factor listed by LetPub is 2.16; CiteScore 4.2, h-index 121.
How long does peer review take at Therapeutic Drug Monitoring?
Based on the dates recorded on 84 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 75 days (interquartile range 57–106 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Therapeutic Drug Monitoring in?
The journal's website gives JCR Q2; by category, MEDICAL LABORATORY TECHNOLOGY Q2 (14/33), PHARMACOLOGY & PHARMACY Q3 (226/356), TOXICOLOGY Q3 (78/106). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Therapeutic Drug Monitoring?
According to LetPub and DOAJ records, Therapeutic Drug Monitoring is indexed in SCIE and Scopus.
Is Therapeutic Drug Monitoring open access, and what is the APC?
Therapeutic Drug Monitoring is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .